Moreover, increased CD8+ T-cell infiltration and tumor volume reduction was observed in mice treated with a combination of radiotherapy and the CHK1 inhibitor AZD7762 compared with treatments with these agents individually (Chao et al. 2020). Here, CHEK1 is linked to neoplasm.